[HTML][HTML] HTLV-1 infection: An emerging risk. Pathogenesis, epidemiology, diagnosis and associated diseases
E Eusebio-Ponce, E Anguita… - Revista Española de …, 2019 - ncbi.nlm.nih.gov
ABSTRACT The Human T-Lymphotropic Virus type 1 (HTLV-1) affects up to 10 million
people worldwide. It is directly associated to one of the most aggressive T cell malignancies …
people worldwide. It is directly associated to one of the most aggressive T cell malignancies …
HTLV-1 and Co-infections
C Rosadas, GP Taylor - Frontiers in Medicine, 2022 - frontiersin.org
Human T lymphotropic virus type 1 (HTLV-1) is a retrovirus that causes lifelong T-cell
infection in humans, impacting the host immune response. This virus causes a range of …
infection in humans, impacting the host immune response. This virus causes a range of …
Epidemiological aspects and world distribution of HTLV-1 infection
A Gessain, O Cassar - Frontiers in microbiology, 2012 - frontiersin.org
The human T-cell leukemia virus type 1 (HTLV-1), identified as the first human oncogenic
retrovirus 30 years ago, is not an ubiquitous virus. HTLV-1 is present throughout the world …
retrovirus 30 years ago, is not an ubiquitous virus. HTLV-1 is present throughout the world …
Reducing the global burden of HTLV-1 infection: an agenda for research and action
Even though an estimated 10–20 million people worldwide are infected with the oncogenic
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases
DU Gonçalves, FA Proietti, JGR Ribas… - Clinical microbiology …, 2010 - Am Soc Microbiol
Human T-cell leukemia virus type 1 (HTLV-1), the first human retrovirus to be discovered, is
present in diverse regions of the world, where its infection is usually neglected in health care …
present in diverse regions of the world, where its infection is usually neglected in health care …
[PDF][PDF] HTLV in the Americas: challenges and perspectives
ABF Carneiro-Proietti… - … de Salud Pública, 2006 - SciELO Public Health
The first description of the human T-lymphotropic virus type 1 (HTLV-1) was made in 1980,
followed closely by the discovery of HTLV-2, in 1982. Since then, the main characteristics of …
followed closely by the discovery of HTLV-2, in 1982. Since then, the main characteristics of …
HTLV-1, the other pathogenic yet neglected human retrovirus: from transmission to therapeutic treatment
N Futsch, R Mahieux, H Dutartre - Viruses, 2017 - mdpi.com
Going back to their discovery in the early 1980s, both the Human T-cell Leukemia virus type-
1 (HTLV-1) and the Human Immunodeficiency Virus type-1 (HIV-1) greatly fascinated the …
1 (HTLV-1) and the Human Immunodeficiency Virus type-1 (HIV-1) greatly fascinated the …
Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies
G Schierhout, S McGregor, A Gessain… - The Lancet Infectious …, 2020 - thelancet.com
Background Human T-cell lymphotropic virus type 1 (HTLV-1) is a human retrovirus that
causes a lifelong infection. Several diseases, including an aggressive form of leukaemia …
causes a lifelong infection. Several diseases, including an aggressive form of leukaemia …
Adult T-cell leukemia/lymphoma and HTLV-1
R Mahieux, A Gessain - Current hematologic malignancy reports, 2007 - Springer
Human T-cell leukemia/lymphoma virus type 1 (HTLV-1) was the first oncogenic human
retrovirus to be discovered, more than 25 years ago. HTLV-1 infects 15 to 20 million …
retrovirus to be discovered, more than 25 years ago. HTLV-1 infects 15 to 20 million …
Seroprevalence and risk factors for human T-cell lymphotropic virus (HTLV 1) infection among ethnically and geographically diverse Peruvian women
C Sanchez-Palacios, E Gotuzzo, AM Vandamme… - International journal of …, 2003 - Elsevier
Objective: To assess the seroprevalence and risk factors for HTLV-I infection in Peruvian
women. Methods: Five hundred and sixty-eight healthy women> 20 years of age from three …
women. Methods: Five hundred and sixty-eight healthy women> 20 years of age from three …